简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-04-06 10:55 Brazilian Healthcare Technology Company Secures Sensitive Data With Thales
2023-04-04 09:18 Wyss Center Geneva Appoints Erwin Böttinger as new Chief Executive Officer
2023-03-31 19:15 Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
2023-03-31 19:11 Joe Kiani Wins 2023 Robert L. Wears Patient Safety Leadership Award
2023-03-31 11:16 Takeda Announces Results From Phase 4 Vedolizumab Study in Patients With Chronic Pouchitis Published in New England Journal of Medicine
2023-03-30 18:24 Thermo Fisher Scientific and Arsenal Biosciences Collaborate to Support Clinical Manufacturing of Autologous T-Cell Therapies
2023-03-30 15:14 USound and Partners to Deliver Next-Generation Over-the-Counter Hearing Aid
2023-03-30 13:38 AMWC 2023: Data From Sculptra® Cheek Wrinkle and Alluzience® Star Studies Reinforce Strength of Galderma’s Broad Aesthetic Portfolio
2023-03-29 18:24 ANANDA Scientific Announces First Patient Enrolled in FDA-approved Clinical Trial Evaluating a Potential New Treatment for Social Anxiety Disorder (SAD)
2023-03-29 16:51 Boehringer Ingelheim reaches more patients than ever in 2022 as innovative medicines drive growth
2023-03-28 09:58 Merck Strengthens Oncology Franchise by Securing Exclusive Worldwide Rights to Anti PD-L1 Antibody BAVENCIO® (avelumab)
2023-03-22 20:18 José Baselga Research Fund Announces First-Ever Grant to Advance Prion Disease Research
2023-03-22 16:06 Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the Treatment of Pancreatic Cancer
2023-03-22 15:28 ‘Medical Korea 2023 Conference’ on Global Medical Industry Prospects to Kick off on March 23 at Coex
2023-03-22 10:07 Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors
2023-03-20 09:08 AAD 2023: Late-Breaking Phase III Results Demonstrate nemolizumab’s Significant Impact on Prurigo Nodularis
2023-03-20 09:06 Takeda Announces Positive Results in Phase 2b Study of Investigational TAK-279, an Oral, Once-Daily TYK2 Inhibitor, in People with Moderate-to-Severe Plaque Psoriasis
2023-03-17 19:05 Avania Names MedTech Industry Veteran, Todd M. Pope, New Chairman of the Board
2023-03-17 15:25 USound Launches Kore 4.0 – The Ultimate Audio Solution for TWS and OTC Hearing Aids
2023-03-17 15:16 Exscientia to Report Full Year 2022 Financial Results on March 23, 2023

Business Wire Weibo

Press Releases

Latest Releases